FLT3 receptor antagonists for the treatment or the prevention of pain disorders
US10106798B2 · kind B2 · utility
0Cited by
4References
3Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Jul 26, 2017 |
| Grant date | Oct 23, 2018 |
| Priority date | — |
| Expiry date | Jul 26, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2842
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to FLT3 receptor antagonists or inhibitors of FLT3 receptor gene expression for the treatment or the prevention of pain disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.